Browsing Tag
Mike Mahoney
2 posts
Boston Scientific (BSX) Q2 2026 beats estimates as MiRus TAVR investment reshapes strategy
Boston Scientific lifted FY 2026 guidance and disclosed a $1.5B MiRus TAVR bet, but BSX trades near 52-week lows as softer Q3 growth guidance stings.
Boston Scientific to acquire Baylis Medical Company for $1.7bn
Boston Scientific has agreed to acquire Baylis Medical Company, a Canadian medical devices manufacturer in the field of…